Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer

Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer

Ewelina Grywalska,1 Marcin Pasiarski,2,3 Stanisław Góźdź,3,4 Jacek Roliński1 1Department of Clinical Immunology and Immunotherapy, Medical University of Lublin, Lublin, Poland; 2Department of Hematology, Holy Cross Oncology Center of Kielce, Kielce, Poland; 3Faculty of Health Sciences, J...

Full description

Bibliographic Details
Main Authors: Grywalska E, Pasiarski M, Góźdź S, Roliński J
Format: Article
Language:English
Published: Dove Medical Press 2018-10-01
Series:OncoTargets and Therapy
Subjects:
B- and T cell lymphocyte attenuator
cytotoxic T cell antigen 4
lymphocyte-activation gene 3
programmed cell death protein 1
T cell exhaustion
T cell immunoglobulin and mucin domain 3
checkpoint inhibitors
Online Access:https://www.dovepress.com/immune-checkpoint-inhibitors-for-combating-t-cell-dysfunction-in-cance-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/immune-checkpoint-inhibitors-for-combating-t-cell-dysfunction-in-cance-peer-reviewed-article-OTT

Similar Items